The Vagus Nerve and Stroke
Watch or Listen
(Membership required to take quiz and earn CEUs.)
Course Quiz
Choose a CEU plan to take this course quiz!
Plans & PricingCourse Introduction
It feels like in every practice area, the importance of the vagus nerve is being talked about.
But nowhere is it being researched as much as vagal nerve stimulation post-stroke. And the initial results are promising — as long as it is paired with rehabilitation. The stimulation sets the body up for new motor learning, but then the rehab actually creates the change.
In this beginner’s course, I’m excited to talk to Sarah Blair, OTR/L from Vivistim about what she has learned about this relatively new intervention and what generalist OTs need to know about this option.
Learning Objectives
You will identify the components of rehabilitation interventions paired with vagus nerve stimulation to show significant improvement.
You will recognize how functional improvements are assessed for vagus nerve stimulation and rehabilitation.
Agenda
Intro
Discussion
Tell me about your OT journey to working for a VNS company.
What have you learned about the vagus nerve and its role in recovery?
I want to give a short overview of a systematic review on VNS. What jumps out to you in this article?
Walk us through the mechanics of VNS stimulation.
What type of therapy is paired with it? And do therapists need special training?
How is success being measured?
How much does VNS cost, and how do patients access it?
Who is VNS a best fit for currently? And, who is NOT a candidate?
What do you personally see as the future of VNS and stroke rehab?
Live Q&A
Closing
Supporting Research
* The meta-analysis mentioned in this podcast episode includes different VNS therapies that works via different mechanisms of action. To read clinical studies specific to paired VNS Therapy, you can check out the Vivistim clinical bibliography page. You can also check out the Vivistim safety standards here.
Transcript
-
Sarah Lyon
It feels like in every therapy practice area, the importance of the vagus nerve is being talked about. But one of the areas where it's actually being the most researched is vagus nerve stimulation post-stroke, and the initial results are promising as long as the stimulation is paired with rehab. What we're finding is that the vagus nerve stimulation sets the body up for new motor learning, but then the rehab actually helps create the change.
In today's episode, I'm excited to talk to Sarah Blair, OTR/L from Vivistim about what she has learned about this relatively new intervention and what generalist therapists need to know about this option. So let's dive in.
Welcome to the OT Potential Podcast. I'm your host, Sarah Lyon, OTR/L, and I wanted to let you know that this podcast may qualify as continuing education for you. You are probably listening to this podcast on a free podcast platform, but to gain CEU credit, you will need to be a member of the OT Potential Club, our OT continuing education platform.
You can go to otpotential.com to learn more. Okay, here we go.
As I mentioned at the top, we are joined today by Sarah Blair. Sarah is an experienced occupational therapist with subject matter expertise spanning from neurological, infant, and burn rehabilitation. Sarah previously worked at Riley Hospital for Children for five years and has also held roles in private outpatient and early intervention settings, building a well-rounded foundation across the spectrum of pediatric care.
Sarah is fascinated by neuro recovery and neuroplasticity. She joined the Mobia Medical team in December 2025 as the Indiana therapy development specialist, bringing her passion for connecting clinicians and families with innovative treatment options for those searching for continued recovery. As a financial disclosure, I wanted to let you know that Mobia Medical is the creator of Vivistim, which is who Sarah works for.
Vivistim is the first and only FDA-approved implantable VNS device for stroke rehab. But that being said, I just truly believe Sarah is the best person to connect the advances in this new health tech category to real-life therapy practice. So without further ado, we will patch Sarah into our live studio.
Hello, Sarah. Welcome to OT Potential.
-
Sarah Blair
Hi, Sarah. Thank you so much for having me. I'm super excited to be here.
-
Sarah Lyon
This is truly an exciting topic. It's not that often that we get to talk about just a relatively new intervention related to rehab. As I look at the space, I'm just... Yeah, I'm excited about it. I feel like it brings visibility to the science of rehab, to the importance of that high repetition, task-specific practice that we talk about a lot on the podcast.
It talks, it brings visibility to the importance of, vagal tone and getting the body, in the right space for learning. And I'm also just excited because it is bringing investment into rehab. Having this health tech solution to pair with rehab just has brought, it feels new players into this space that's so important.
Helping people post-stroke is, such just, important on the global agenda. it's exciting to see real advances in this area. We have so many fun details to talk about today, about the science, about what's out there, but I really want to begin with just hearing your story. I know that you've spent time as a practicing OT, then have been on this health tech journey.
I'd love to hear about that and then how you ended up in this vagus nerve stimulation space.
-
Sarah Blair
Yeah, sure. I'd love to share a little bit. yeah, so I'm an OT, and a big part of my early background, like you said, was in peds. worked in a bunch of different settings with a wide variety of diagnosis, and I saw, firsthand how every patient's story and recovery path is so different.
I've always been a why person, like, why are we doing this way? Why does this work for one patient and not another? And then over time, I realized that, while I loved patient care, I really also wanted a broader reach, and became interested in how to support therapies and programs and systems, not just one patient at a time.
I realized I was really excited about health tech and med tech and got involved with an AI-assisted documentation system, and worked there, got some really great experience there, and it just really opened my eyes to what else was available that I could do as an OT. And with- through that, I was exposed to Vivistim, and it really clicked for me.
It really brought together my OT background, love for neuroplasticity, functional recovery, technology, and then it keeps good skilled therapy at the center and as the central part of the recovery and treatment option. And that is so exciting because it is such a good fit for occupational therapy and occupational therapists have to be central to this role.
so I just find that so validating and exciting and empowering to be a part of.
-
Sarah Lyon
I love when, OTs get to transition to health tech companies. It's such an important role to have people with that, practice experience at these companies. Can you tell us just a little bit just about your role at Vivastim, just to help orient us a little bit more- Yeah
to what you're doing day to day?
-
Sarah Blair
Absolutely. So I am, the therapy development specialist for the Indiana-Indianapolis region territory, and my job is really to connect clinicians, patients, and their care partners with Vivastim therapy through education, awareness events, really getting into the clinic spaces to see how their therapy spaces are working, figure out best ways to get those patients that need therapy, need Vivastim therapy as an option, connected with care.
So from a day to day, it varies, but I am, very often speaking with patients, con- connecting with therapists in the clinic, watching treatment sessions, training on how to get, the actual therapy protocol going, doing refreshers on good quality neuro assessments for patients. So I'm really able to still be a part of the therapeutic process, which is so exciting for me, while being able to help people connect with this really new and exciting intervention.
-
Sarah Lyon
So much in health tech we hear about the hope of finding the things that really augment therapy, and I think what makes me so excited looking at this technology is it is just a true augmentation, a true supercharge of what is happening in therapy. I have just, a billion logistical questions about what that looks like, but I want to start us just at, the highest level of the understanding the vagus nerve and the role of it.
It's really interesting here on the podcast, as I get to talk to experts in different areas, I actually hear a lot about the vagus nerve in all kinds of different practice areas. I think there's a huge trend for therapists in beginning their session with some kind of activity that, really sets the vagal tone, deep breathing or some other health tech device to really get the body into a state of learning.
Let's just say that's all I know. Can you walk me through 101, why are therapists doing that? What do I need to know about the vagus nerve to understand this conversation that we're
-
Sarah Blair
about to have? Absolutely. if we're talking vagus nerve 101 here, I'll say that the science is still evolving a lot.
there's not... we're right at the beginning of understanding what the vagus nerve is involved in. but the simple area, answer is that it's involved with a lot. we hear about the vagus nerve in wellness spaces a lot. you're- we're seeing cold plunges, and we're seeing ice packs in the center of the chest, and we're seeing, deep rumbling noises to stimulate the vagus nerve.
And while that's all super exciting and fascinating, there are areas of vagus nerve stimulation that do have, decades of medical and neuroscience research behind it too. so that's what we'll be talking about today, how that's evolved to incorporate into stroke recovery. So you might know that, the vagus nerve is often associated with the fight or flight, rest and digest.
but it is the longest cranial nerve in the body, and it's a major communication highway between the brain and the body. So signals are running both to the brain, with, through the left v- branch of the vagus nerve and to the rest of the body, including the heart, on, through the right branch of the vagus nerve.
But it's got big... plays a big part in regulation generally, getting you up and ready to do something exciting or calming you down afterwards. stress regulation, heart rate, digestion, sleep, all of those things. I didn't realize before learning about VivaStem how important it was for your brain processes, executive functioning, attention, learning, memory, neuroplasticity.
So it was really exciting to learn about that. What we know is that stimulation to the vagus nerve sends signals through brainstem pathways, which can influence and help release neuromodulators in the brain, including norepinephrine, serotonin, acetylcholine. it's not activating the arm part of the brain to help the arm move, but what it's doing is it's activating and helping to turn on the learning centers of the brain so that therapy, at that point, your high quality neuro rehab therapy and principles are even more effective.
So you're priming your brain to be ready to learn new things and rebuild, repair, reroute neural pathways that were damaged in a stroke So with paired VNS, the stimulation is paired with movement. That's where the paired VNS comes from, and it's almost like telling the brain, "Hey, pay attention. This movement is important."
And so it's like a, "Hey brain, pay attention." I don't know if snaps go through on podcasts, but pay attention. This is important. this is something that you want to learn and want to really integrate. So the key takeaway with the vagus nerve is that the VNS is not making the muscles move, and it's not replacing therapy, and it doesn't work if the therapy is not taking place at the same time.
So the therapy still does the work. The therapy is the therapy, but the VNS may help enhance or does help enhance the brain's ability to respond to the therapy and, makes it become more effective.
-
Sarah Lyon
What a great way to put all that. I'm try- I'm trying to wrap my brain around it. I'm even just trying to wrap my brain around, the language that's being used.
I wanna ask just a couple language questions.
-
Sarah Blair
Yes.
-
Sarah Lyon
is the goal, you would say, to, stimulate... You're trying to stimulate a vagus tone that is in learning mode? And is that in rest and digest mode or activated? what, what's What are, the words that you use around that?
-
Sarah Blair
Yeah. So I actually don't use the word vagal tone too much.
Okay. Okay. And that may be something that I can look into further. but the way I think of it is actually how I think about, preparation for a pediatric session too. So what I want to do is focus on regulation and connection first. So with pedes, those are things like that's proprioceptive input.
That's heavy work. That's, making sure that we're connected. It's the same idea. We are priming the brain's ability to be ready to learn. If we don't have regulation first, we're not gonna be able... The other things won't stick. So what the vagus nerve stimulation is doing is releasing those neuromodulators, which is basically just turning the brain and into, it, putting it into a heightened learning environment.
-
Sarah Lyon
That Totally makes sense. It's just really helpful to, conceptualize it in that way. I want to ask next about some of the research that's come out. As you've mentioned, this has been studied, vagus nerve stimulation has been studied for a long time. There's been this renew- this new focus around post-stroke rehab.
I pulled one of the most recent systematic reviews that came out. It's called "The Effect of Vagus Nerve Stimulation on the Rehabilitation of Stroke: A Systematic Review and Meta-Analysis." It just came out, this winter of 2026, and walked through the state of the science just to say out loud for people who, don't have this article in front of them, which, probably no one does since they're listening to this podcast.
But, it launched with this idea that vagus nerve stimulation has already been an established intervention for epilepsy, drug-resistant depression, pain, and chronic tyni- tinnitus. And then in 2021, the Food & Drug Administration approved the first paired VNS device for patients with moderate to severe upper limb dysfunction following an ischemic stroke.
So it entered into this post-stroke, post-stroke area with those parameters around it. That's for ischemic stroke and for that upper limb dysfunction. Then, the goal of the study was to look at the, effect on that group of people, and they looked at multiple, randomized control trials, 16 of them with 819 patients.
They were looking at ADL swallowing function and emotional state. And what the study found was significant improvement in upper extremity function through the Fugl-Meyer and Wolf Motor test, significant improvement in ADLs through the Barthel and Modified Barthel, significant improvement in stroke, post-stroke depression by the Hamilton Depression Rating Scale and HADS, and then no significant improvement in swallowing.
but the numbers on swallowing were really small in the systematic review. So that was summarizes the current state of the literature where we're at the point where we've had multiple randomized control, controlled trials. They're being able to pull the data into meta-analysis, and they're seeing this just, across the board positive improvement.
When I look at the study, I just see this, growing body of evidence behind this intervention. I'm curious with your eyes and your expertise as you look at this, what stood out to you, in this latest research?
-
Sarah Blair
Yeah. So I think what jumps out to me most is just the consistency and the growing interest across the literature.
So it's not just one study or one isolated result. We are really seeing with pretty high confidence that vagus nerve stimulation is very beneficial for stroke recovery, and that is extremely exciting. And then also, the benefits weren't just limited to motor scores. I really liked how they looked at things that were especially meaningful for patients, their ADLs, their functional goals.
They looked at mood and, depression and all of those things. And I think that's super important to take into consideration as occupational therapists, of course, that we are looking at the whole person and we're not just looking at how well the arm can move, after this. I also felt like it was interesting, that there were so many transcutaneous approaches that were included, as the only FDA-approved option is the implanted paired VNS.
So that is, a, an implant that is connected directly to the vagus nerve that is able to offer, stimulus at the specific time of therapy. and then, because no ev-ev-evidence is not all the same across the board, different stimulation parameters, therapy protocols and populations, there's different device approaches.
So we have to look closely at what's actually studied, to really tease apart all of that data. And then I also did want to mention the study that wasn't included, if that's okay. we have, the pivotal trial that led to the paired VNS FDA approval in 2021, published in The Lancet, was a
multicenter randomized, triple-controlled or triple-blinded, sham-controlled, and paired with a standardized rehab. So the rigor of the actual research is pretty high. and we were able to see with all of those controls in place, how the paired VNS was able to assist in the improvement of upper extremity function And then I think the last thing through all of this, as an OT, what resonates for me mostly is that the vagus nerve stimulation was not used instead of therapy.
Again, it was paired with intensive rehab, high repetition, task spe- specific practice, and meaningful movement, and that's, that's our whole shtick, right? we know, what works for neuro rehab and, it's very exciting to see that the research is backing up that this therapy approach works, and here's a way to make it even more effective.
we're not working on trying to replace therapists or rehab with this device. It's something to potentially help patients get more work... get more from the work that they're already doing.
-
Sarah Lyon
It's so interesting how it, as you said, just, supercharges what's already going on, and I really wanna drill into that, what they call, the mechanism of action, 'cause I don't fully understand it yet.
What the article said, at the end, they talked about the mechanism of action, which they're like, "We're still exploring exactly why this works," but it seems like the three general things are stimulating the vagus nerve creates this anti-inflammatory and neuroprotective effects. It enhances neuroplasticity by regulating neuroep- epinephrine and serotonin, which you mentioned already, and then there...
it also just does this network modulation, influencing brain connectivity and cortical excitability. So- Walk me through... I just want, to understand, exactly what's happening. So here in the United States, you get an implanted device. Where's it at? How does it get, triggered? What do we think is happening as you're explaining it to people?
walk me through the logistics of what's happening here.
-
Sarah Blair
sure. So what we know so far is that, that this is effective for adults with chronic ischemic stroke that have a moderate to severe upper extremity deficit. So pa- these patients are going through several steps of, evaluation and approval.
And then once they get evaluated by an occupational therapist or a physical therapist and get surgically cleared and have the surgery, the surgery itself is, it's two incisions, one usually on the left chest and one on the left neck, just a couple centimeters. it's an outpatient procedure, and the patients go home the same day.
There's a, IPG or, a little, connective battery generator that is put in the chest. And then there's a lead that goes up and coils around the vagus nerve, the left vagus nerve. Specifically the left vagus nerve because 80% of those nerve fibers are afferent and are going to the brain and talking to the brain, versus, the right vagus nerve, which goes to the body, including the AV nodes of the heart, and we're not wanting to mess with those.
So we always connect, to the left vagus nerve. And then in terms of the stimulation, like you said, there's probably several things that are happening at once that make this effective. What we know it-- likely is happening is that signals from the vagus nerve are traveling through the brain stem, specifically through the nucleus tractus solitarius or NTS.
And then from there, the pathways connect with areas like the locus coeruleus, the raphe nuclei, and which-- and those are the things that are involved in releasing norepinephrine, serotonin, acetylcholine, things like that. What we know about those chemicals is that they're tied to attention, learning, memory, neuroplasticity generally, and they help the brain to recognize what's important and what's worth learning.
So when you're giving those stimuli at the same time as completing the high-quality neuro rehab, you are getting the benefits of those neuro rehab principles, high repetition, salient, mass practice variable, plus your brain is ready to receive that learning. and then what that actually looks like in practice is the patient has the device im-implanted And the clinician has, a computer, we call it the SAPS, with a transmitter that pairs with the patient's implant, and then they have a clicker so they can actually physically click to send stimulation to the vagus nerve at the most important part of those movements that, the patient wants to recover or relearn.
So it's very interesting and very precise how we're able to send those signals to the brain to say, "This part's important." And I just find that extremely fascinating because you're working in, that precision piece where you can really focus in on the parts of the activity that are important, even more so than your basic parts practice, within a task.
So it's very exciting. And then that's where the pairing is important, right? The stimulation is delivered during those movements and not randomly throughout the day, not when you're sitting on the couch and watching Netflix or- ... or, during, when you're sleeping. So you're doing...
You're getting the vagus nerve stimulation at the same time as the movements. So it, it... Recovery requires the brain to relearn the movement, so therapy provides the practice, and the vagus nerve stimulation helps to create the brain state to be more receptive to learning from that practice.
And it just is, it's really exciting that we're able to, again, be able to be really specific about when we're providing the stimulation in clinic. And then additionally, patients will receive a magnet that they are able to swipe over their device for home practice. And so that provides them up to, eight 30-minute sessions throughout a 24-period, hour period of time that they're able to swipe before morning routine, before daily housework, before cooking, before their leisure activities.
So in, on top of high quality neuro rehab principles that are happening in clinic at a pretty high frequency therapy, we're also getting the really super functional patient at home putting in the work while getting vagus nerve stimulation through the magnet and home program.
-
Sarah Lyon
Wow. It's all so mind-blowing to think about how we're able to harness this brain state that we've known w- like, opens the door for new learning.
and then to also think about stacking it on top of, if you're post-stroke, especially those first three months, you're already in a state of heightened neuroplasticity, and then you're able to heighten the potential learning even more. I am very curious about the role of the therapist. Some of my questions are, do they need special training?
Do they get approved beforehand? It sounds like, you would be doing therapy that's really familiar to any stroke therapist. but what can you tell me about the partnership with a therapist, and what might be different than a stroke patient who doesn't have this technology?
-
Sarah Blair
Yeah, good question. I wanna, bounce back for one second and just give a quick clarification.
For what we've studied so far is the effects of paired VNS therapy in the chronic stage. So we haven't looked-
yet at the implantable vagus nerve stimulator in the acute phase. Oh, interesting. And we haven't really wanted to mess with the spontaneous recovery that's happening, and instead, waiting until recovery slows down a little bit and reboosting the rate of neuroplasticity or a neuro rehab at that point.
So we're letting, letting, acute rehab do its thing and spontaneous recovery do its thing, and then coming in and giving another boost so that recovery, that quicker recovery is prolonged as long as possible or as long as the patient needs.
-
Sarah Lyon
Super interesting. Yeah, that makes sense to study it in that phase when you're in a- Yes
plateau and it's, quote, "normalized," so you can really see the effect size.
-
Sarah Blair
Absolutely. And we're, we're right at the beginning of the research. Who knows in the future where all we are able, we're gonna be able to go with this. but it is... it's exciting that we have such positive results with these first couple of studies that have come out.
Back to your question about training for the therapists. so like you said, with Vivistim, the therapy that is occurring is high quality neuro rehab following the principles that therapists are already using for neuro rehab therapy. specificity, repetition, intensity, salience, variability, transference, all of those things that should be very familiar to a neuro therapist, those are the things we're doing during treatment.
So that part, not, no additional specific training is needed. The standard Vivistim in-clinic protocol is a six-week protocol three times a week for 90 minutes. That is more than most outpatient therapists are doing with their chronic stroke survivors. So we do provide resources on, best practice for how to fill that time and how to make sure that we're getting the amount of reps that are required to make a neuroplastic change.
So we have lots of resources available, to assist with treatment planning, magnet home program tracking, different ways to provide those functional activities for patients. So we have resources, but that part is not, not foreign to the therapist. We do provide training on how to use the SAPS computer that we provide to clinics, how to power it on, how to click, how many times to click per, rep, how many reps we wanna get, 300 to 500, per session.
And then how to make sure that the pa- the patients are correctly swiping their magnet so they get the benefit of the vagus nerve stimulation at home as well. And then we also use the Fugl-Meyer assessment as our pre and post, outcome measure. so if there are therapists that haven't used that, we have some resources and refresher materials to, to help people feel comfortable with that.
we train the therapist on the system, but they already know how to do the therapy.
-
Sarah Lyon
Yes. Yeah. In the, article and all the studies that have been done, I was looking at how success is being measured across the studies, and it all felt, very familiar. Like you said, there's the Fugl-Meyer, they were looking at the Berg Balance scale, functional communication, the FIM, fatigue severity scale, modified Barthel.
they were looking at wide varieties of what, the effect is. I'm curious, as you're working with therapists in the United States, you mentioned the Fugl-Meyer, is there any other ways that you, are tracking success with patients on a regular basis, or just areas that you hope to see success in?
-
Sarah Blair
Yeah, absolutely. So we do, recommend the Fugl-Meyer. it's helpful for insurance reimbursement and, achieving or, getting prior authorization if needed. But we have therapists that are doing all kinds of outcome measures in addition. the Fugl-Meyer is a key measure, and patient selected goals are obviously always very important, so we're going to be tracking success against those.
We see therapists using range of motion, box and blocks, nine-hole peg, grip strength, pi- pinch strength, lots of different, your stroke impact scale. all those things are being used regularly within the clinic setting, to track progress. some of those were also used in our, our pivotal trial as well, and it's interesting because all of the results graphs looked very similar, and we saw improvement across the board in all of those measures, including the depression scales, which is a whole nother area that is- Yeah
-
Sarah Lyon
so fascinating. Really interesting.
-
Sarah Blair
Yeah. But my favorite way to track pract- or track progress or track success is, our Vivostim victories. So we're internally we like to talk about and share things that patients have done that are really exciting to see. So we've seen, recently patients that have been able to go fishing for the first time since their stroke, throwing a ball with their kids, or playing guitar, or dancing with their spouse, or holding their grandkids.
And of course, those are the things that really matter. The patients don't really care if they got... some of them do. They'll say, "I improved 12 points in my Fugl-Meyer," and that's super exciting to them. But, at the end of the day, what's important is what can they do now, what function have they, has returned that they're able to utilize within their day-to-day life to improve their wellbeing.
And so that, that part's my favorite. what are the patients bragging about after the therapy's over?
-
Sarah Lyon
So emotional, es- especially thinking about chronic stroke too, where there's probably a reality where the patient may have given up hope on finding the next level of improvement.
And, I think as therapists, we know that there's almost always the possibility for improvement, but this, having this paired device just really supercharges and opens that window. I wanna go back just a second, ask one clarifying question about getting trained. Is... Do you get a certification when you're trained, or, what does the therapist have to basically show insurance to let them know that they're good to go to provide therapy?
-
Sarah Blair
Yeah, no certification is required. there's no additional education needed. It is informal at this point. It's possible in the future that we're looking towards, something different, but, we don't have any additional requirements for therapists to be able to provide this. What we do have, though, is, some free CEU courses that, are available for therapists that want to dig a little bit deeper and learn a little bit more about, the mechanisms and how to provide good quality therapy to different levels of function, for patients. So we have, some... a really good recorded webinar that, talks about what to do with your lower level patients and how to make sure that they're able to engage with therapy for those full sessions.
So no, no certification, formal certification required, but there is support and training for therapists that would like to learn more, and would like to make sure they have all the context. And then each area, each territory, that is providing Vivostim therapy will have a therapy development specialist, which is me for Indiana, Indianapolis, and, a territory manager, which, my partner Jacob might be on the call.
He and I work together to help connect, patients, therapists, care providers together. So if you were to have somebody, a therapist were to have somebody that they were interested in talking about Vivostim with, what we would do is have you reach out to your local Vivostim therapy development specialist.
you can do that through me. You can do that on the website. and they would help connect you. But again, no formal certificate, but we have lots of resources for you.
-
Sarah Lyon
I'll definitely have to connect with you to get those free courses too, 'cause I have a list on my website that I try to keep active of free courses- Awesome
and I don't have those on there, but I will get those to people. I wanna ask one more clinical question before I ask about cost and referral. Those questions are piling up in my mind, but my last clinical question is I'm thinking about getting closer to discharge and maintenance. from what you've said, it sounds like the protocol is six weeks.
Is that right currently? Yes. Okay. So you do your six weeks, you still have an implanted device. What does maintenance look like for people? Do some people extend therapy? Kind of what happens after therapy for these patients?
-
Sarah Blair
Yeah. So it's, exciting because the, again, the research is ongoing for this and we, we are still following what happens long term.
What we know is that patients that have completed their therapy up to a year ago have maintained their progress- from that initial therapy stint that they got with the, with Vivistim therapy. Patients can do a variety of different things, and at that point we are... that's up to the patient and the clinician.
The therapy is billed the same way that it's billed otherwise. So there's no specific Vivistim code. You're billing therapeutic activity, therapeutic exercise, neural re-ed, any of those things, and then the Vivistim is a modality that you're using on top of that. So it can be... You can continue therapy. You can continue weekly.
You can continue every other. You can have the patient come in, in three months for check-ins or do what they call the dental model and have them come in every six months or a year. And this is all, these are all things that ideally we'll continue to gather research on and inform be- best practice. But at this point, what's best for the patient, the clinician, and what's allowed with insurance is how we're making those decisions.
But the therapist can continue using the clicker with the SAPS, with the paired VNS during therapy when the patient is there, and the patient will be, still be able to swipe the magnet and do the home practice as well to continue to get the benefit of the paired vagus nerve stimulation during their functional home activities.
And then the battery life is about five years with typical use. So at that point, again, several things can happen. It can stay put. It's not gonna hurt anything. If the patient is done using it and they've reached the goals that they'd like to reach, they can just- Forget that it's there and just- Yeah
le- leave it be. We can talk to help them connect with providers, and talk about a battery exchange. So we might be able to, if patients are still getting benefit out of it, just replace the battery. and who knows? We might have a next gen that is, I don't know, will make your breakfast for you too.
No, not really. and then if you really are not liking it at the end, the option, of course, is always there to get it explanted, and that would be a patient-surgeon discussion at that point. Newly added, we have a, a long-term follow-up team that is able to, and is dedicated to following up with patients long term after the conclusion of their Vivistim therapy, with the goal that they can, of course, receive feedback on the Vivistim process, but also to be able to provide resources, help them get reconnected with therapy if needed, and to help refine the long-term care process, as well as make sure that those patients maintain a connection that is often lost in chronic stroke patients, so that connection to the medical system and medical care, in regards to their stroke recovery.
-
Sarah Lyon
I'm really hopeful that the research that you all are gathering and seeing the success will just, raise all boats in stroke rehab. right now it feels like we have to fight so hard for the hours that we know patients need. So it makes me excited to just see more research coming out about the...
Or we know that we need high intensity task specific practice, but apparently we need more research, we need more advocacy to really get those hours, and I love just what you're putting out there and the model that you're, helping to make a reality for people. I wanna ask about referral and cost. Yes.
I wanna preface that a little bit, swinging back to the systematic review that we looked at the beginning. That review was actually out of China and looking at, what's happening globally, and they had multiple studies on the transcutaneous option. But, so that is being studied, but it felt like the results were more variable.
That hasn't been approved here in the United States by the FDA for post-stroke. So when you're talking about c- cost and referral, you're talking about the implantable option. So if someone... I'm sitting in my little outpatient therapy office in Aurora, Nebraska. I get a s- chronic stroke patient on my caseload who I think would be a good fit.
Walk me through referral process. My question being like, should I go to the doctor first, or should I go to you all first and you go to the doctor? and then What kind of cost is that patient looking at, Yeah ... financial insurance coverage?
-
Sarah Blair
Yeah. the... Our pathway is also can be varied. if you as a clinician know about Vivistim, but have no additional knowledge and haven't b- been in contact with one of us, the first thing you could do is contact, if you h- know your contact information for your local Vivistim TDS, you can do that.
contact them, and they can help you walk through that entire process. If you don't know your local Vivistim rep, you can go to the website, and even just do the connect form, the get started form, and fill out a survey, and then your local rep will quickly reach out to you to get connected.
Once you are ready to start, the process and you feel comfortable with what the process is, the first step for a patient to become eligible to get this implant is an occupational therapy evaluation, including this Fugl-Meyer. If they're already on caseload, it c- doesn't have to be an e- it doesn't have to be billed as an eval.
It just has to be in the, in your documentation as, the medical necessity blurb with the Fugl-Meyer score and, the impact on functional activities that the impairment is currently causing. If the patient does not... is not already on caseload with a therapist, then w- we are able to help them.
We as, the Vivistim TDSs and ther- territory managers are able to help connect them with their provider to get a referral for therapy. But another thing that I like about this is because, therapy is so integral to the whole process, it makes sense that it's also the first door that patients cross through, so that conversation between the patient and the therapist can occur to see, is this really the right option for you, knowing that, knowing everything that it entails From the OT evaluation that is submitted, the documentation is submitted to us, and then we can, as well as to your EMRs of course, so we can help with the prior authorization process and connect that patient with a surgeon in the area, a neurosurgeon, in the area that is doing the implants for a surgical consult.
The surgeon at that point then is the one that, that determines, surgical clearance, medical clearance. So as a therapist, you don't have to think through all of that part. All you have to do as a therapist, that first step, is determine is this patient a, fall within the moderate to severe category of upper extremity impairment, and do they wanna pursue Vivastim?
So those are the only two things that you have to tease out, and then they go to the surgical consult, and then at that point, we hit what is the most variable timeline of the process, which is prior authorization. Which I know we are all so familiar with and know and despise, primarily.
But we have a pass-through with Medicare, traditional Medicare, so no prior author- prior authorization is needed for Medicare patients, traditional Medicare patients. We do require prior authorization for Medicaid patients, commercial plans, and Medicare replacement and advantage plans. We have a team called our market access team that assists with obtaining prior authorization and dealing with denials and r- and appeals as they come through, and we have a pretty high success rate of getting the prior authorization approved.
At that point, once we have approval, we would, the patient would move through to scheduling surgery. They would have a, three to... or two to four-week wait between surgery and a follow-up appointment with their surgeon and when they start their therapy protocol. And then the TDSs and territory manager are involved in those steps of the process as well, for the patient and connecting the patient to their clinics and assisting with making sure scheduling is completed because, again, it is a high-frequency timeline for the treatment.
Let me
-
Sarah Lyon
repeat this. Yeah, yes. Okay. Let me repeat this back to you. A patient with an ischemic stroke with moderate upper extremity dysfunction per the Fugl-Meyer, someone who, wants to do a, a more intensive protocol, they have to be up for that part of it. And maybe you said this, but is there a point post-stroke that they have to be, three months out, six months out?
Is there a timeline there that works for authorization typically?
-
Sarah Blair
What we want to see is documented chronicity. So we want to see that they have-- they've been doc- documented to be at the chronic stage. Okay. That's typically around six months. but what they're looking for is a slowdown of the progress or of a plateau.
And if they're at that, four, four to five-month region and you think that they are in a chronic phase and have data and your outcome measures to support that, then we can move forward at that point
-
Sarah Lyon
This has all been so helpful to understand all these details. I want to zoom us to the future a little bit.
I had a question in the comments how long Vivistim has been around. It seems like it got approved in 2021. Is that right?
-
Sarah Blair
Yes.
-
Sarah Lyon
Yep.
-
Sarah Blair
Yeah.
-
Sarah Lyon
So we're still early in this world, in what's possible in the research. Exciting things are happening now. I'm curious with your, insider view on what's going on, what do you see in the future of this?
Like more adoption, more... Yeah, I don't know. Yeah, what gets you excited about the future here?
-
Sarah Blair
Yeah, so much, and how exciting is it to truly be right at the beginning of this? I feel like we're, we've just opened, the prologue, so it's extremely exciting to be at this point.
and we're still learning how to optimize neuromodulation for recovery, again, right at the beginning about this process. Yeah. So you know, it's just... it's really thrilling. There's more to understand about s- patient selection and timing and dosing, and how to get the best outcomes for stroke survivors.
So I'm excited to see the research come in, about that and see how to really refine best practice surrounding this. And, the biggest thing that I'm hopeful for is that we can really shift the conversation away from your recovery stops after six months, 'cause it... there's just so much new data that's coming out, and, it's supported by the American Stroke, American Heart Associations that neuroplasticity is not time limited, and it can continue throughout the lifespan.
So I, I really am hopeful that in the future that is m- much more widely adopted and understood, 'cause I think that could have such a big impact on patient mental health and wellbeing in their recovery, knowing that there's no... You don't have to make all your gains in the first four to six months after therapy.
yes, work hard during that time and you're gonna, see, increased speed of recovery, but it do- it's not over after that. You can still, make progress. So yeah, that... that's hugely hopeful message for, stroke survivors and therapists. I'm also really excited about the growing awareness about paired VNS therapy.
more therapists know about it, more physicians know about it, and then because of that, more stroke survivors are hearing about it. so I'm excited about it just being more, more widely available and known about so that we can continue to reach more and more appropriate patients, that could benefit from it.
Yeah. I think we're really hopeful that we can have this paired VNS therapy for stroke rehab to move into a standard of care for chronic stroke survivors. any chronic ischemic stroke survivor that, is still looking for options, i- is, it's available to them. It's not just, based on where you're located, if that area is already using Vivistim.
It's, standard of care, so everyone knows about it. So that would be the... That's the dream, right? That- everyone can have access. any everyone that is interested and i- is a good candidate would have access. and it's just, it's exciting, and I think that it also feels a little bit like we're bringing it back to this grounded space of the therapy is the foundation of recovery.
the work that you put into therapy is the foundation of the recovery, and the paired VNS is just there to help bolster and help really enhance the progress that you would get with the therapy and the work that you're already putting in. And so I think that, just like you said earlier, raising all the boats in with for stroke rehab, we know good quality neuro rehab is the answer When you add paired VNS, you get even more success.
-
Sarah Lyon
It feels to me like over the course of rehab, the history of rehab, it's taken us, 100 years to through trial and error learn, what works in rehab. we finally landed on, it's this high intensity, task-specific practice, and you need to be in a certain state of neuromodulation.
it took a long time to figure that out, and for the science to catch up to, like, why is that working? Oh, it's working because of the vagus nerve. It's working because of these endorphins are getting released. And just as we're, like, finally understanding where the science is now developing so quickly that we're able to quickly supercharge those things.
So this conversation just, again, brings me back to excitement about shining a light on the hard-earned knowledge that we've earned about the science of rehab, and the new possibilities that technology is opening to supercharge it. And whether people work in stroke rehab or not, I hope this is helpful information just to think about motor learning, about, your...
the neuromodulation state that is most, open to more, to, new learning. Those are my big takeaways from this conversation. Do you have any final thoughts that you would like to leave us on? We've touched on so many different, both, logistics, but also big picture ideas about rehab. What do you want to leave us on today?
-
Sarah Blair
Yeah. I think you, you hit the nail on the head, too. We got... Really, we're standing on the shoulders of all the science that has been done up to this point. Vagus nerve stimulation on its own is not new, but being able to really see the expanded view of what all it can do is the exciting and, novel part.
and again, I think that as occupational therapists and rehab professionals in general, we play such a pivotal role in recovery- It's so nice to now have a way to just turn it on turbo. We're able to really use what we know to be good quality therapy and provide the brain with that enhanced space to be able to learn and make it even more effective.
the, VNS itself is not the therapy. The therapy is the therapy. And it is just so exciting that we can have both to improve outcomes, and that it's becoming more and more available to the patients that can benefit from it.
-
Sarah Lyon
Sarah, this has been so fun. I love when practicing therapists make the leap into health tech and then share what they're learning with us on the ground, and I love this just trajectory that you've been on, and that we really get to see that augmentation of rehab.
we talk about that as a hypothetical a lot, and it's so fun to, see someone who's found that as their career and to see that really happening for such an important population, in our country and in our world. I'm so thankful to just be able to talk about the new science for stroke survivors.
So thank you so much for being here today, for sharing, and just thank you for this conversation.
-
Sarah Blair
Oh my gosh, thank you so much for having me. It has been a joy, and it's always just so fun chatting with you.
-
Sarah Lyon
Thank you for joining us on the OT Potential podcast. To earn one hour of AOTA-approved continuing education for your time today, you will need to sign in or sign up at otpotential.com. Once you're in the OT Potential Club, you will find a five-question post-course quiz connected to this episode. When you pass the quiz with a score of 75% or higher, you will be able to download a PDF certificate that certifies your completion of this course.
Okay, I wanna thank you for joining us today, and we'll see you next time.
Professions
Contact Hours (CEUs/PDUs)
1 Contact Hour. Released online from Aurora, NE.
This course was designed to meet your continuing education requirements
We designed our courses to meet the requirements for “online” and “independent/self-study” courses. To verify the requirements from your specific state (within the U.S.), check out OT Continuing Education Requirements. If you are outside of the United States and don't see requirements for your specific location on that page, please contact us.
OT Potential courses are presented as live webinars, then released on-demand video and audio via the OT Potential Podcast. Attendance in the live webinar will be indicated on your certificate. Learn more about how our courses help meet live webinar requirements, and OT CEU requirements overall.
We are proud to be an AOTA Approved Provider and to meet the requirements for your NBCOT renewal.
AOTA Details
AOTA Course ID#: 16384
AOTA CEUs Earned: 0.1
AOTA Delivery Format: Distance Learning-Independent
AOTA Category: OT Service Delivery
AOTA Level: Introductory
NBCOT Details
NBCOT PDUs Earned: 1.25
Instructional Methods, Registration, Special Needs Requests, Cancellation Policy
This course is an independent/self-study course delivered via podcast on one or more of the following platforms: YouTube, Apple Podcasts, Spotify, & Google Play.
If you need accommodations to take this course, please contact us and we will address your needs on an individual basis.
If we cancel a promoted course, event, live stream, or any other paid CEU offering prior to release, and you subscribe explicitly for said offering, you are eligible for a full refund if you did not complete and earn any other CEU quizzes or certificates during your subscription.
If a live webinar is cancelled that you signed up for, our system will automatically generate an email to you and if possible, we will inform you of the rescheduled date. Our most current webinar schedule will be found here.
Audience / Education Level & Course Completion Requirements
Our target audience is therapy professionals who are looking to learn more about this topic. The educational level is introductory. In order to receive a certificate for this course, you must first participate in the podcast/webinar in its entirety. Then, you will need to take the quiz that will accompany the course and earn 75% or higher. If you pass, a PDF certificate will be made available to you via email and download. Quizzes for live (distance learning–interactive) webinars must be completed within 3 days of completing the webinar.
Disclosures
It is the policy of OT Potential to disclose any financial and non-financial interest the provider or instructor may have in a product or service mentioned during an activity. This is to ensure that the audience is made aware of any bias of the speaker.
OT Potential pays guest speakers an honorarium for their participation, either directly or to an institution of the speaker's choosing at their request. We invite guests whose expertise often comes from practices, programs, or building products in their field. Where a speaker has a financial interest in the subject of a course, we disclose it below so you can weigh it for yourself.
OT Potential's interest in this topic: We have no financial stake in vagus nerve stimulation or in any device discussed in this course.
Speaker interests: Sarah Blair is employed by Mobia Medical, which distributes the Vivistim Paired VNS System — the device discussed in this course. Because paired VNS is currently available from a limited number of manufacturers, much of the clinical evidence discussed comes from studies of a single device.
Speakers
Sarah Lyon, OTR/L, is the CEO of OT Potential. Sarah earned her BA from St. Olaf College and her master’s degree in occupational therapy from New York University. Her diverse clinical background spans multiple settings, including critical access, acute trauma, and state inpatient psychiatric hospitals. In 2011, she founded OT Potential to fulfill the industry's need for reliable, high-quality occupational therapy resources and continuing education.
As a recognized content creator, Sarah has collaborated with top healthcare brands like VeryWell Health, WebPT, and MedBridge. She blends her clinical expertise with a talent for creating clear, action-oriented content that empowers practitioners to excel. Passionate about elevating the OT profession, she has been featured on numerous industry podcasts. Sarah ultimately returned to her roots, running OT Potential and raising her family in her hometown of Aurora, Nebraska.